title: Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy.
abstract: BACKGROUND
  Sarcoidosis is an inflammatory disease characterized by non-caseating granulomas that can be present in diverse organ systems. Sarcoidosis can be associated with malignancy, presenting either preceding, during, or after chemotherapy. We herewith report a case of sarcoidosis mimicking cancer recurrence that developed after radioactive iodine therapy for papillary thyroid cancer.
  
  
  BACKGROUND
  A 68-year-old Caucasian woman was found to have an incidental mediastinal lymph node. She underwent biopsy, which revealed sarcoidosis. There was no further treatment or evidence of recurrence over the ensuing 9 years. She was then diagnosed with low-grade papillary thyroid cancer in the right posterior lobe and treated with total thyroidectomy followed by radioactive iodine therapy. Six months later, she was found to have elevated serum thyroglobulin. Post-remnant ablation scan showed increased tracer uptake in the bed of the thyroid. Though two thyroid ultrasound scans were negative, she was treated with I-131 for possible recurrence. She then developed right hip pain, prompting further investigation. Though a skeletal survey was negative, an 18-fluorodeoxyglucose positron emission tomography (PET) scan study revealed multiple hypermetabolic skeletal lesions in both humeri and the proximal left femur. In addition, hypermetabolic hilar and mediastinal nodes were noted. As widespread cancer metastasis was suspected, bone biopsy was performed, which showed non-caseating granulomas, consistent with recurrence of sarcoidosis.
  
  
  CONCLUSIONS
  Sarcoid lesions may mimic metastatic disease or recurrence in oncologic patients. Biopsy and histopathology examination should be performed to confirm the diagnosis. Recurrence or reactivation of sarcoidosis has been proposed to result from altered immunologic milieu because of the presence of either active cancer or its therapy. Teodorovic and colleagues postulated that the radioactive I-131 therapy leads to reduced secretion of Th2 cytokines such as interleukin (IL)-4, IL-5, and IL-13. Few case reports of sarcoidosis associated with papillary carcinoma have been published; this is the first report of systemic recurrence of sarcoidosis associated with papillary thyroid carcinoma after treatment with radioactive iodine therapy.
authors: Department of Medicine, MedStar Good Samaritan Hospital, Baltimore, MD, USA; zinnfang@gmail.com.
authors: Zin W
authors: ZW
authors: Myint
authors: Department of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA.
authors: Robert D
authors: RD
authors: Chow
keywords: PET scan; cancer metastasis; papillary thyroid cancer; radioactive iodine therapy; sarcoidosis
references: Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):207-9
references: 22980128
references: Am J Respir Crit Care Med. 2004 Dec 15;170(12):1324-30
references: 15347561
references: N Engl J Med. 2007 Nov 22;357(21):2153-65
references: 18032765
references: Cancer Treat Rev. 1986 Sep;13(3):147-56
references: 3536088
references: Ann Hematol. 2002 Feb;81(2):103-5
references: 11907791
references: Cancer Res Treat. 2013 Dec;45(4):354-8
references: 24454009
references: Br J Cancer. 1974 Mar;29(3):247-51
references: 4830144
references: Acta Med Scand. 1988;223(1):83-7
references: 3126625
references: Eur J Cancer. 1970 Dec;6(6):545-51
references: 5504464
references: Cancer Immunol Immunother. 2015 Jan;64(1):75-82
references: 25297452
references: Int J Health Sci (Qassim). 2008 Jan;2(1):109-12
references: 21475480
references: Chest. 1995 Mar;107(3):605-13
references: 7874925
references: Gynecol Oncol. 2005 Dec;99(3):770-3
references: 16168469
references: South Med J. 2003 Sep;96(9):918-22
references: 14513992
references: Cancer Res Treat. 2014 Jul;46(3):317-21
references: 25038768